Plasma Fractionation Market By Product Type (Immunoglobulins {Intravenous Immunoglobulins, Subcutaneous Immunoglobulins, Other Immunoglobulins}, Coagulation Factor Concentrates {Factor VIII, Factor IX, Von Willebrand Factor, Prothrombin Complex Concentrate, Fibrinogen Concentrates, Factor XIII, Other Coagulation Factor Concentrates}, Albumin {Human albumin, Recombinant albumin} Protease Inhibitors, Others), By Method (Centrifugation, Depth Filtration, Chromatography, Others), By Application (Neurology, Immunology, Haematology, Critical care, Pulmonology, Hemato-Oncology, Rheumatology, Other .), By Distribution channel (Direct Sales, Distributors, Online sales), and By End-user (Hospitals and Clinics, Clinical Research Laboratories, Academic institutes, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Plasma Fractionation Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Rising prevalence of chronic and rare diseases requiring plasma-derived therapies.

3.2.2. Advancements in plasma fractionation technologies improving efficiency.

3.2.3. Supportive government initiatives and funding for plasma research.

3.3. Key industry pitfalls & challenges

3.3.1. High production and processing costs of plasma-derived products.

3.3.2. Stringent regulatory requirements impacting market entry.

3.3.3. Ethical and logistical challenges in plasma donor recruitment.

3.4. Market Opportunities

3.4.1. Expansion of plasma collection centres in underpenetrated regions.

3.4.2. Innovations in recombinant alternatives reduce production costs.

3.4.3. Growing focus on personalized medicine using plasma-derived therapies.

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Plasma Fractionation Market, Product Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Product Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Immunoglobulins

4.2.1. Intravenous Immunoglobulins

4.2.1.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.2. Subcutaneous Immunoglobulins

4.2.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.3. Other Immunoglobulins

4.2.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Coagulation Factor Concentrates

4.3.1. Factor VIII

4.3.1.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.2. Factor IX

4.3.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.3. Von Willebrand Factor

4.3.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.4. Prothrombin Complex Concentrate

4.3.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.5. Fibrinogen Concentrates

4.3.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.6. Factor XIII

4.3.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.7. Other Coagulation Factor Concentrates

4.3.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Albumin

4.4.1. Human albumin

4.4.1.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.2. Recombinant albumin

4.4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.5. Protease Inhibitors

4.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.6. Other

4.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Plasma Fractionation Market, Method Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Method, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Centrifugation

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Depth Filtration

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. Chromatography

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Others

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Plasma Fractionation Market, Application Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Application, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Neurology

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Immunology

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4. Haematology

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.5. Critical care

6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.6. Pulmonology

6.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.7. Hemato-Oncology

6.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.8. Rheumatology

6.8.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.9. Other

6.9.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Plasma Fractionation Market, Distribution Channel Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Distribution Channel, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Direct sales

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Distributors

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Online sales

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. Plasma Fractionation Market, End-user Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By End-user, 2025 & 2035

8.1.2. Key Market Trends, Growth Factors, & Opportunities

8.2. Hospitals and Clinics

8.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.3. Clinical Research Laboratories

8.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.4. Academic institutes

8.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.5. Others

8.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

9. Plasma Fractionation Market, Region Segment Analysis

9.1. Overview

9.1.1. Global Market Revenue Share, By Region, 2025 & 2035

9.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)

9.2. North America

9.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)

9.2.2. North America Market Revenue, By Product Type, 2025-2035

9.2.3. North America Market Revenue, By Method, 2025-2035

9.2.4. North America Market Revenue, By Application, 2025-2035

9.2.5. North America Market Revenue, By Distribution Channel, 2025-2035

9.2.6. North America Market Revenue, By End-user, 2025-2035

9.2.7. The U.S.

9.2.7.1. U.S. Market Revenue, By Product Type, 2025-2035

9.2.7.2. U.S. Market Revenue, By Method, 2025-2035

9.2.7.3. U.S. Market Revenue, By Application, 2025-2035

9.2.7.4. U.S. Market Revenue, By Distribution Channel, 2025-2035

9.2.7.5. U.S. Market Revenue, By End-user, 2025-2035

9.2.8. Canada

9.2.8.1. Canada Market Revenue, By Product Type, 2025-2035

9.2.8.2. Canada Market Revenue, By Method, 2025-2035

9.2.8.3. Canada Market Revenue, By Application, 2025-2035

9.2.8.4. Canada Market Revenue, By Distribution Channel, 2025-2035

9.2.8.5. Canada Market Revenue, By End-user, 2025-2035

9.3. Europe

9.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)

9.3.2. Europe Market Revenue, By Product Type, 2025-2035

9.3.3. Europe Market Revenue, By Method, 2025-2035

9.3.4. Europe Market Revenue, By Application, 2025-2035

9.3.5. Europe Market Revenue, By Distribution Channel, 2025-2035

9.3.6. Europe Market Revenue, By End-user, 2025-2035

9.3.7. Germany

9.3.7.1. Germany Market Revenue, By Product Type, 2025-2035

9.3.7.2. Germany Market Revenue, By Method, 2025-2035

9.3.7.3. Germany Market Revenue, By Application, 2025-2035

9.3.7.4. Germany Market Revenue, By Distribution Channel, 2025-2035

9.3.7.5. Germany Market Revenue, By End-user, 2025-2035

9.3.8. France

9.3.8.1. France Market Revenue, By Product Type, 2025-2035

9.3.8.2. France Market Revenue, By Method, 2025-2035

9.3.8.3. France Market Revenue, By Application, 2025-2035

9.3.8.4. France Market Revenue, By Distribution Channel, 2025-2035

9.3.8.5. France Market Revenue, By End-user, 2025-2035

9.3.9. U.K.

9.3.9.1. U.K. Market Revenue, By Product Type, 2025-2035

9.3.9.2. U.K. Market Revenue, By Method, 2025-2035

9.3.9.3. U.K. Market Revenue, By Application, 2025-2035

9.3.9.4. U.K. Market Revenue, By Distribution Channel, 2025-2035

9.3.9.5. U.K. Market Revenue, By End-user, 2025-2035

9.3.10. Italy

9.3.10.1. Italy Market Revenue, By Product Type, 2025-2035

9.3.10.2. Italy Market Revenue, By Method, 2025-2035

9.3.10.3. Italy Market Revenue, By Application, 2025-2035

9.3.10.4. Italy Market Revenue, By Distribution Channel, 2025-2035

9.3.10.5. Italy Market Revenue, By End-user, 2025-2035

9.3.11. Spain

9.3.11.1. Spain Market Revenue, By Product Type, 2025-2035

9.3.11.2. Spain Market Revenue, By Method, 2025-2035

9.3.11.3. Spain Market Revenue, By Application, 2025-2035

9.3.11.4. Spain Market Revenue, By Distribution Channel, 2025-2035

9.3.11.5. Spain Market Revenue, By End-user, 2025-2035

9.3.12. Rest of Europe

9.3.12.1. Rest of Europe Market Revenue, By Product Type, 2025-2035

9.3.12.2. Rest of Europe Market Revenue, By Method, 2025-2035

9.3.12.3. Rest of Europe Market Revenue, By Application, 2025-2035

9.3.12.4. Rest of Europe Market Revenue, By Distribution Channel, 2025-2035

9.3.12.5. Rest of Europe Market Revenue, By End-user, 2025-2035

9.4. Asia Pacific

9.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Billion)

9.4.2. Asia Pacific Market Revenue, By Product Type, 2025-2035

9.4.3. Asia Pacific Market Revenue, By Method, 2025-2035

9.4.4. Asia Pacific Market Revenue, By Application, 2025-2035

9.4.5. Asia Pacific Market Revenue, By Distribution Channel, 2025-2035

9.4.6. Asia Pacific Market Revenue, By End-user, 2025-2035

9.4.7. China

9.4.7.1. China Market Revenue, By Product Type, 2025-2035

9.4.7.2. China Market Revenue, By Method, 2025-2035

9.4.7.3. China Market Revenue, By Application, 2025-2035

9.4.7.4. China Market Revenue, By Distribution Channel, 2025-2035

9.4.7.5. China Market Revenue, By End-user, 2025-2035

9.4.8. Japan

9.4.8.1. Japan Market Revenue, By Product Type, 2025-2035

9.4.8.2. Japan Market Revenue, By Method, 2025-2035

9.4.8.3. Japan Market Revenue, By Application, 2025-2035

9.4.8.4. Japan Market Revenue, By Distribution Channel, 2025-2035

9.4.8.5. Japan Market Revenue, By End-user, 2025-2035

9.4.9. India

9.4.9.1. India Market Revenue, By Product Type, 2025-2035

9.4.9.2. India Market Revenue, By Method, 2025-2035

9.4.9.3. India Market Revenue, By Application, 2025-2035

9.4.9.4. India Market Revenue, By Distribution Channel, 2025-2035

9.4.9.5. India Market Revenue, By End-user, 2025-2035

9.4.10. Australia

9.4.10.1. Australia Market Revenue, By Product Type, 2025-2035

9.4.10.2. Australia Market Revenue, By Method, 2025-2035

9.4.10.3. Australia Market Revenue, By Application, 2025-2035

9.4.10.4. Australia Market Revenue, By Distribution Channel, 2025-2035

9.4.10.5. Australia Market Revenue, By End-user, 2025-2035

9.4.11. South Korea

9.4.11.1. South Korea Market Revenue, By Product Type, 2025-2035

9.4.11.2. South Korea Market Revenue, By Method, 2025-2035

9.4.11.3. South Korea Market Revenue, By Application, 2025-2035

9.4.11.4. South Korea Market Revenue, By Distribution Channel, 2025-2035

9.4.11.5. South Korea Market Revenue, By End-user, 2025-2035

9.4.12. Singapore

9.4.12.1. Singapore Market Revenue, By Product Type, 2025-2035

9.4.12.2. Singapore Market Revenue, By Method, 2025-2035

9.4.12.3. Singapore Market Revenue, By Application, 2025-2035

9.4.12.4. Singapore Market Revenue, By Distribution Channel, 2025-2035

9.4.12.5. Singapore Market Revenue, By End-user, 2025-2035

9.4.13. Rest of Asia Pacific

9.4.13.1. Rest of Asia Pacific Market Revenue, By Product Type, 2025-2035

9.4.13.2. Rest of Asia Pacific Market Revenue, By Method, 2025-2035

9.4.13.3. Rest of Asia Pacific Market Revenue, By Application, 2025-2035

9.4.13.4. Rest of Asia Pacific Market Revenue, By Distribution Channel, 2025-2035

9.4.13.5. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

9.5. Latin America

9.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Billion)

9.5.2. Latin America Market Revenue, By Product Type, 2025-2035

9.5.3. Latin America Market Revenue, By Method, 2025-2035

9.5.4. Latin America Market Revenue, By Application, 2025-2035

9.5.5. Latin America Market Revenue, By Distribution Channel, 2025-2035

9.5.6. Latin America Market Revenue, By End-user, 2025-2035

9.5.7. Brazil

9.5.7.1. Brazil Market Revenue, By Product Type, 2025-2035

9.5.7.2. Brazil Market Revenue, By Method, 2025-2035

9.5.7.3. Brazil Market Revenue, By Application, 2025-2035

9.5.7.4. Brazil Market Revenue, By Distribution Channel, 2025-2035

9.5.7.5. Brazil Market Revenue, By End-user, 2025-2035

9.5.8. Argentina

9.5.8.1. Argentina Market Revenue, By Product Type, 2025-2035

9.5.8.2. Argentina Market Revenue, By Method, 2025-2035

9.5.8.3. Argentina Market Revenue, By Application, 2025-2035

9.5.8.4. Argentina Market Revenue, By Distribution Channel, 2025-2035

9.5.8.5. Argentina Market Revenue, By End-user, 2025-2035

9.5.9. Mexico

9.5.9.1. Mexico Market Revenue, By Product Type, 2025-2035

9.5.9.2. Mexico Market Revenue, By Method, 2025-2035

9.5.9.3. Mexico Market Revenue, By Application, 2025-2035

9.5.9.4. Mexico Market Revenue, By Distribution Channel, 2025-2035

9.5.9.5. Mexico Market Revenue, By End-user, 2025-2035

9.5.10. Rest of Latin America

9.5.10.1. Rest of Latin America Market Revenue, By Product Type, 2025-2035

9.5.10.2. Rest of Latin America Revenue, By Method, 2025-2035

9.5.10.3. Rest of Latin America Market Revenue, By Application, 2025-2035

9.5.10.4. Rest of Latin America Market Revenue, By Distribution Channel, 2025-2035

9.5.10.5. Rest of Latin America Market Revenue, By End-user, 2025-2035

9.6. MEA

9.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Billion)

9.6.2. MEA Market Revenue, By Product Type, 2025-2035

9.6.3. MEA Market Revenue, By Method, 2025-2035

9.6.4. MEA Market Revenue, By Application, 2025-2035

9.6.5. MEA Market Revenue, By Distribution Channel, 2025-2035

9.6.6. MEA Market Revenue, By End-user, 2025-2035

9.6.7. GCC Countries

9.6.7.1. GCC Countries Market Revenue, By Product Type, 2025-2035

9.6.7.2. GCC Countries Market Revenue, By Method, 2025-2035

9.6.7.3. GCC Countries Market Revenue, By Application, 2025-2035

9.6.7.4. GCC Countries Market Revenue, By Distribution Channel, 2025-2035

9.6.7.5. GCC Countries Market Revenue, By End-user, 2025-2035

9.6.8. South Africa

9.6.8.1. South Africa Market Revenue, By Product Type, 2025-2035

9.6.8.2. South Africa Market Revenue, By Method, 2025-2035

9.6.8.3. South Africa Market Revenue, By Application, 2025-2035

9.6.8.4. South Africa Market Revenue, By Distribution Channel, 2025-2035

9.6.8.5. South Africa Market Revenue, By End-user, 2025-2035

9.6.9. Rest of Middle-East & Africa

9.6.9.1. Rest of Middle-East & Africa Market Revenue, By Product Type, 2025-2035

9.6.9.2. Rest of Middle-East & Africa Market Revenue, By Method, 2025-2035

9.6.9.3. Rest of Middle-East & Africa Market Revenue, By Application, 2025-2035

9.6.9.4. Rest of Middle-East & Africa Market Revenue, By Distribution Channel, 2025-2035

9.6.9.5. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

10. Company Profile

10.1. CSL Behring

10.1.1. Business Overview

10.1.2. Financial Performance

10.1.3. Product/Service Offerings

10.1.4. Strategies & recent developments

10.1.5. SWOT Analysis

10.2. Takeda Pharmaceutical Company Limited

10.2.1. Business Overview

10.2.2. Financial Performance

10.2.3. Product/Service Offerings

10.2.4. Strategies & recent developments

10.2.5. SWOT Analysis

10.3. Grifols, S.A.

10.3.1. Business Overview

10.3.2. Financial Performance

10.3.3. Product/Service Offerings

10.3.4. Strategies & recent developments

10.3.5. SWOT Analysis

10.4. Octapharma AG

10.4.1. Business Overview

10.4.2. Financial Performance

10.4.3. Product/Service Offerings

10.4.4. Strategies & recent developments

10.4.5. SWOT Analysis

10.5. Kedrion S.p.A.

10.5.1. Business Overview

10.5.2. Financial Performance

10.5.3. Product/Service Offerings

10.5.4. Strategies & recent developments

10.5.5. SWOT Analysis

10.6. LFB S.A.

10.6.1. Business Overview

10.6.2. Financial Performance

10.6.3. Product/Service Offerings

10.6.4. Strategies & recent developments

10.6.5. SWOT Analysis

10.7. Biotest AG

10.7.1. Business Overview

10.7.2. Financial Performance

10.7.3. Product/Service Offerings

10.7.4. Strategies & recent developments

10.7.5. SWOT Analysis

10.8. Sanquin

10.8.1. Business Overview

10.8.2. Financial Performance

10.8.3. Product/Service Offerings

10.8.4. Strategies & recent developments

10.8.5. SWOT Analysis

10.9. Bio Products Laboratory Ltd.

10.9.1. Business Overview

10.9.2. Financial Performance

10.9.3. Product/Service Offerings

10.9.4. Strategies & recent developments

10.9.5. SWOT Analysis

10.10. China Biologic Products Holdings Inc.

10.10.1. Business Overview

10.10.2. Financial Performance

10.10.3. Product/Service Offerings

10.10.4. Strategies & recent developments

10.10.5. SWOT Analysis

10.11. GC Pharma

10.11.1. Business Overview

10.11.2. Financial Performance

10.11.3. Product/Service Offerings

10.11.4. Strategies & recent developments

10.11.5. SWOT Analysis

10.12. Hualan Bioengineering Co., Ltd.

10.12.1. Business Overview

10.12.2. Financial Performance

10.12.3. Product/Service Offerings

10.12.4. Strategies & recent developments

10.12.5. SWOT Analysis

10.13. Japan Blood Products Organization

10.13.1. Business Overview

10.13.2. Financial Performance

10.13.3. Product/Service Offerings

10.13.4. Strategies & recent developments

10.13.5. SWOT Analysis

10.14. Shanghai RAAS Blood Products Co., Ltd.

10.14.1. Business Overview

10.14.2. Financial Performance

10.14.3. Product/Service Offerings

10.14.4. Strategies & recent developments

10.14.5. SWOT Analysis

10.15. Emergent BioSolutions

10.15.1. Business Overview

10.15.2. Financial Performance

10.15.3. Product/Service Offerings

10.15.4. Strategies & recent developments

10.15.5. SWOT Analysis

10.16. Intas Pharmaceuticals Ltd.

10.16.1. Business Overview

10.16.2. Financial Performance

10.16.3. Product/Service Offerings

10.16.4. Strategies & recent developments

10.16.5. SWOT Analysis